Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome.

Authors: Celli, J  Duijf, P  Hamel, BC  Bamshad, M  Kramer, B  Smits, AP  Newbury-Ecob, R  Hennekam, RC  Van Buggenhout, G  Van Haeringen, A  Woods, CG  Van Essen, AJ  De Waal, R  Vriend, G  Haber, DA  Yang, A  McKeon, F  Brunner, HG  Van Bokhoven, H 
Citation: Celli J, etal., Cell. 1999 Oct 15;99(2):143-53.
Pubmed: (View Article at PubMed) PMID:10535733

EEC syndrome is an autosomal dominant disorder characterized by ectrodactyly, ectodermal dysplasia, and facial clefts. We have mapped the genetic defect in several EEC syndrome families to a region of chromosome 3q27 previously implicated in the EEC-like disorder, limb mammary syndrome (LMS). Analysis of the p63 gene, a homolog of p53 located in the critical LMS/EEC interval, revealed heterozygous mutations in nine unrelated EEC families. Eight mutations result in amino acid substitutions that are predicted to abolish the DNA binding capacity of p63. The ninth is a frameshift mutation that affects the p63alpha, but not p63beta and p63gamma isotypes. Transactivation studies with these mutant p63 isotypes provide a molecular explanation for the dominant character of p63 mutations in EEC syndrome.

Annotation

Disease Annotations
Objects Annotated

Additional Information

 
CRRD Object Information
CRRD ID: 1600403
Created: 2007-03-07
Species: All species
Last Modified: 2007-03-07
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.